#UbiVac
LightNews LightNews
bernardafox.bsky.social
#Bridge2024 coming to a close! Saturday, December 7th 2024 @2:10 pm and we are entering the last session/will cover 1st line #immunotherapy, salvage, igniting change in #cancer #vaccine development, combo IO, #PD1 refractory & more @sitcancer.bsky.social #MSD #BIOTECH #BMS #Merck #Regeneron #UbiVac
December 7, 2024 at 1:26 PM
bernardafox.bsky.social
On Day 1 of 2025 want to thank @oncodaily for shout out & share their post. While early, this is promising news for patients with head & neck #cancer #HNSCC /lots of people responsible Drs. Rom Leidner @rbryanbell.bsky.social @walterurba.bsky.social #FinishCancer #UbiVac #Incyte
t.co/bO0JC32H5A
https://oncodaily.com/insight/211553
t.co
January 2, 2025 at 4:26 AM
bernardafox.bsky.social

💥Yesterday #NEJM: Phase 3 randomized trial for metastatic MSI-H #colorectal #cancer /24-month progression-free survival (PFS) of 72% for #immunotherapy (IPI/NIVO) compared to 14% for #chemotherapy /Next? Vaccines 2 induce T cells to #MSS #DarkMatter #antigens #UbiVac
www.nejm.org/doi/full/10....
Nivolumab plus Ipilimumab in Microsatellite-Instability–High Metastatic Colorectal Cancer | NEJM
Patients with microsatellite-instability–high (MSI-H) or mismatch-repair–deficient (dMMR) metastatic colorectal cancer have poor outcomes with standard chemotherapy with or without targeted therapi...
www.nejm.org
November 28, 2024 at 6:10 PM
oncodaily.bsky.social
Another JP Morgan is in the Books for Me - Bernard A. Fox

@bernardafox.bsky.social

oncodaily.com/voices/jp-mo...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
Bernard A. Fox: Another JP Morgan is in the Books for Me - OncoDaily
Bernard A. Fox: Another JP Morgan is in the Books for Me / Bernard A. Fox, Bernard Fox, cancer, JP Morgan, JPM 2026, JPM2026, OncoDaily, Oncology, UbiVac
oncodaily.com
January 17, 2026 at 12:37 AM
bernardafox.bsky.social
Appreciate @oncodaily publishing LinkedIn post highlighting world’s 1st cancer’s #DarkMatter #immunotherapy! This strategy has tripled response rates! www.einpresswire.com/article/7584... @UbiVac looking to move this off-the-shelf drug to other #cancers @ChilesResearch

oncodaily.com/blog/232771
Bernard A. Fox: UbiVac is excited to have the world’s 1st immunotherapy that targets cancer’s Dark Matter - OncoDaily
Bernard A. Fox: UbiVac is excited to have the world’s 1st immunotherapy that targets cancer’s Dark Matter / Alan Braynin, Alan Korman, Asthika Goonewardene,
oncodaily.com
January 30, 2025 at 5:40 AM
bernardafox.bsky.social
@truebuddhism.bsky.social Treatment trials for #GoldenRetrievers & other #CompanionAnimals incl w/ #immunotherapy & #radiationtherapy are avail/Possible #vaccine 2 prevent cancer in #dogs? #UbiVac thinks so! #FinishCancer #SethPollackLab @NWU + @UWI / uwveterinarycare.wisc.edu/veterinary-c...
Clinical Studies - UW Veterinary CareSite iconsMoreopen menuclosesearchsearchsearchenvelopepinterest-ptwitteryoutubefacebookinstagramCollapseExpandnext slideprevious slideFooter Crest
UV Veterinary Care has clinical studies in cardiology, genetics, neurology, oncology, and ophthalmology for dogs, cats, rabbits, and horses.
uwveterinarycare.wisc.edu
November 28, 2024 at 7:00 PM
bernardafox.bsky.social
@truebuddhism.bsky.social Treatment trials for #GoldenRetrievers & other #CompanionAnimals incl w/ #immunotherapy & #radiationtherapy are avail/Possible #vaccine 2 prevent cancer in #dogs? #UbiVac thinks so! #FinishCancer #SethPollackLab @NWU + @UWI / uwveterinarycare.wisc.edu/veterinary-c...
Clinical Studies in Oncology - UW Veterinary CareSite iconsMoreopen menuclosesearchsearchsearchenvelopepinterest-ptwitteryoutubefacebookinstagramCollapseExpandnext slideprevious slideFooter Crest
uwveterinarycare.wisc.edu
November 28, 2024 at 6:57 PM